William Riordan

Statistics

Publications

Citations

716

H-Index

Active since

1984

Affiliations

Millennium Engineering and Integration (United States)(Current)

CS Diagnostics

Princess Margaret Cancer Centre

UPMC Hillman Cancer Center

William Riordan is an author at Millennium Engineering and Integration (United States) specializing in medicine, bortezomib therapy, and pharmacology.

Publications per year

1984–2010

Publications

Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib

Kai Sun, Angela Panoskaltsis‐Mortari, Matthew J. O’Shaughnessy et al. · Proceedings of the National Academy of Sciences · 2004 · 242 citations · Full text

Medicine, Immunology, Pharmacology +17

Dissociation rate constant of the biotin-streptavidin complex

Uri Piran, William Riordan · Journal of Immunological Methods · 1990 · 131 citations

Natural Sciences, Biochemistry, Molecular Biology +14

Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma

Donna Reece, Dan M. Sullivan, Sagar Lonial et al. · Cancer Chemotherapy and Pharmacology · 2010 · 107 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: A prospective, multicenter, open-label, randomized, two-way crossover drug—drug interaction study

Karthik Venkatakrishnan, Michael Rader, Ramesh K. Ramanathan et al. · Clinical Therapeutics · 2009 · 62 citations

Medicine, Pharmacokinetics, Pharmacology +6

Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator

Li Zhang, Zheng Zhang, Xianshuang Liu et al. · Thrombosis and Haemostasis · 2005 · 58 citations

Medicine, Neuroscience, Pharmacology +17

1–5 of 9